Ask AI
ProCE Banner Activity

Insights From an Educational Program on the Evolving Treatment Landscape for Gynecologic Cancers

Clinical Thought

Read this commentary with expert takeaways from an educational program covering the latest advances for targeted therapies used in the management of gynecologic cancers, along with answers to frequently asked questions from attendees at a series of live educational workshops. 

Released: September 02, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Smart Patients

ProCE Banner

Supporters

Supported by educational grants from GlaxoSmithKline and Merck Sharp & Dohme LLC.

GlaxoSmithKline

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner

Disclosure

Primary Author

Ebony R. Hoskins, MD, FACOG, has no relevant financial relationships to disclose.

Kathleen N. Moore, MD, MS, FASCO: consultant/advisor/speaker: Aadi, AbbVie, AstraZeneca, Blueprint, Caris, Corcept, Daiichi Sankyo, Duality, Eisai, Genentech/Roche, GlaxoSmithKline, Immunogen, Janssen, Loxo-Lilly, Merck, Mersana, Novartis, Regeneron, Schrödinger, Takeda, Verastem, Zentalis, Zymeworks.